Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P C Fuchs

Showing results (181-190 of 257) with videos related to

Pageof 26
Sort By:
The American Journal of the Medical Sciences|November 1, 1977
Ticarcillin: a collaborative in vitro comparison with carbenicillin against over 9,000 clinical bacterial isolatesP C Fuchs, T L Gavan, E H Gerlach, et al.
Diagnostic Microbiology and Infectious Disease|November 1, 1989
Piperacillin/tazobactam (YTR 830) combination. Comparative antimicrobial activity against 5889 recent aerobic clinical isolates and 60 Bacteroides fragilis group strainsR N Jones, M A Pfaller, P C Fuchs, et al.
Journal of Clinical Microbiology|January 1, 1987
Quality control limits for microdilution susceptibility tests with norfloxacinA L Barry, T L Gavan, L W Ayers, et al.
Proceedings of the Royal Society of Medicine|October 5, 2010
Cefuroxime, an in vitro Comparison with Six Other CephalosporinsA L Barry, C Thornsberry, R N Jones, et al.
The Journal of Antibiotics|December 1, 1977
Ticarcillin, carbenicillin and BL-P1908. In vitro comparison of three anti-pseudomonal semisynthetic penicillinsP C Fuchs, C Thornsberry, A L Barry, et al.
The Journal of Antibiotics|December 1, 1977
Piperacillin (T-1220), a new semisynthetic penicillin: in vitro antimicrobial activity comparison with carbenicillin, ticarcillin, ampicillin, cephalothin, cefamandole and cefoxitinR N Jones, C Thornsberry, A L Barry, et al.
Burns : Journal of the International Society for Burn Injuries|March 12, 2018
Response to Letter to the Editor: 'Experience with NexoBrid<sup>®</sup> in enzymatic debridement of facial burns'A Schulz, P C Fuchs, I Rothermundt, et al.
Diagnostic Microbiology and Infectious Disease|January 1, 1988
Antimicrobial activity of U-76,252 (CS-807), a new orally administered cephalosporin ester, including recommendations for MIC quality controlR N Jones, A L Barry, M Pfaller, et al.
The Journal of Antibiotics|July 1, 1977
BL-S786, a new parenteral cephalosporin. II. In vitro antimicrobial activity comparison with six related cephalosporinsR N Jones, C Thornsberry, A L Barry, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1981
Cefmenoxime (SCE-1365), a new cephalosporin: in vitro activity, comparison with other antimicrobial agents, beta-lactamase stability, and disk diffusion testing with tentative interpretive criteriaP C Fuchs, R N Jones, C Thornsberry, et al.
Pageof 26

Showing results (181-190 of 257) with videos related to

Sort By:
Pageof 26
The American Journal of the Medical Sciences|November 1, 1977
Ticarcillin: a collaborative in vitro comparison with carbenicillin against over 9,000 clinical bacterial isolatesP C Fuchs, T L Gavan, E H Gerlach, et al.
Diagnostic Microbiology and Infectious Disease|November 1, 1989
Piperacillin/tazobactam (YTR 830) combination. Comparative antimicrobial activity against 5889 recent aerobic clinical isolates and 60 Bacteroides fragilis group strainsR N Jones, M A Pfaller, P C Fuchs, et al.
Journal of Clinical Microbiology|January 1, 1987
Quality control limits for microdilution susceptibility tests with norfloxacinA L Barry, T L Gavan, L W Ayers, et al.
Proceedings of the Royal Society of Medicine|October 5, 2010
Cefuroxime, an in vitro Comparison with Six Other CephalosporinsA L Barry, C Thornsberry, R N Jones, et al.
The Journal of Antibiotics|December 1, 1977
Ticarcillin, carbenicillin and BL-P1908. In vitro comparison of three anti-pseudomonal semisynthetic penicillinsP C Fuchs, C Thornsberry, A L Barry, et al.
The Journal of Antibiotics|December 1, 1977
Piperacillin (T-1220), a new semisynthetic penicillin: in vitro antimicrobial activity comparison with carbenicillin, ticarcillin, ampicillin, cephalothin, cefamandole and cefoxitinR N Jones, C Thornsberry, A L Barry, et al.
Burns : Journal of the International Society for Burn Injuries|March 12, 2018
Response to Letter to the Editor: 'Experience with NexoBrid<sup>®</sup> in enzymatic debridement of facial burns'A Schulz, P C Fuchs, I Rothermundt, et al.
Diagnostic Microbiology and Infectious Disease|January 1, 1988
Antimicrobial activity of U-76,252 (CS-807), a new orally administered cephalosporin ester, including recommendations for MIC quality controlR N Jones, A L Barry, M Pfaller, et al.
The Journal of Antibiotics|July 1, 1977
BL-S786, a new parenteral cephalosporin. II. In vitro antimicrobial activity comparison with six related cephalosporinsR N Jones, C Thornsberry, A L Barry, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1981
Cefmenoxime (SCE-1365), a new cephalosporin: in vitro activity, comparison with other antimicrobial agents, beta-lactamase stability, and disk diffusion testing with tentative interpretive criteriaP C Fuchs, R N Jones, C Thornsberry, et al.
Pageof 26